The Breast Cancer Survivorship Institute, Kaiser Permanente, Sacramento, CA.
Perm J. 2020;24. doi: 10.7812/TPP/19.129.
Patients with a current diagnosis of breast cancer are enjoying dramatic cure rates and survivorship secondary to an increase in awareness, earlier detection, and more effective therapies. Although strategies such as Breast Cancer Awareness Month in October focus on early detection, lifestyle changes are seldom discussed other than dietary concerns and physical activity. Lifestyle modifications centered on diet and exercise have been demonstrated to affect overall disease-free survival in breast cancer. Since the early 2000s, the role of the human gut microbiota and its relation to breast cancer has become a major area of interest in the scientific and medical community. We live and survive owing to the symbiotic relationship with the microorganisms within us: the human microbiota. Scientific advances have identified a subset of the gut microbiota: the estrobolome, those bacteria that have the genetic capability to metabolize estrogen, which plays a key role in most breast cancers. Recent research provides evidence that the gut microbiome plays a substantial role in estrogen regulation. Gut microbiota diversity appears to be an essential component of overall health, including breast health. Future research attention should include a more extensive focus on the role of the human gut microbiota in breast cancer.
目前被诊断患有乳腺癌的患者由于对疾病的认识提高、早期检测和更有效的治疗方法,其治愈率和存活率都有了显著提高。虽然像 10 月的“乳腺癌宣传月”这样的策略侧重于早期发现,但除了饮食问题和身体活动外,很少讨论生活方式的改变。以饮食和运动为中心的生活方式改变已被证明会影响乳腺癌的无病总生存率。自 21 世纪初以来,人类肠道微生物群及其与乳腺癌的关系已成为科学界和医学界的一个主要研究领域。我们依靠与体内微生物的共生关系生存:人类微生物群。科学进步已经确定了肠道微生物群的一个亚群:即雌激素代谢物组,这些细菌具有代谢雌激素的遗传能力,而雌激素在大多数乳腺癌中起着关键作用。最近的研究提供了证据,表明肠道微生物组在雌激素调节中起着重要作用。肠道微生物多样性似乎是整体健康的一个重要组成部分,包括乳房健康。未来的研究重点应该包括更广泛地关注人类肠道微生物群在乳腺癌中的作用。